KRAS Mutant Solid Tumors
Oncology
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
Phase 1(1)
| Drug | Company |
|---|---|
| tln-372 | IGM Biosciences, Inc. (IGMS) |
Compare drugs
Frequently asked questions
How many drugs are in development for KRAS Mutant Solid Tumors?
BioSniper tracks 2 drugs in development for KRAS Mutant Solid Tumors across 1 company.
How many clinical trials target KRAS Mutant Solid Tumors?
There are 1 clinical trial targeting KRAS Mutant Solid Tumors tracked by BioSniper.
Deep-dive into KRAS Mutant Solid Tumors
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis